Drug General Information (ID: DDI7QAUHLS)
  Drug Name Interferon alfa-2a, Recombinant Drug Info Niraparib Drug Info
  Drug Type Interferons Small molecule
  Therapeutic Class Interferons Poly (Adp-Ribose) Polymerase Inhibitors

 Mechanism of Interferon alfa-2a, Recombinant-Niraparib Interaction (Severity Level: Moderate)
     Additive immunosuppressive effects Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Interferon alfa-2a, Recombinant Niraparib
      Mechanism Myelosuppressive effects Myelosuppressive effects
      Key Mechanism Factor 1
Factor Name Immunosuppressive effects
Factor Description Immunosuppression is when your immune system is not functioning as it should. The immune system is made up of cells, tissues and organs that help the body fight off infections. If the immune system is suppressed, an infection that your body was able to control may become serious or even fatal.
      Mechanism Description
  • Additive immunosuppressive effects by the combination of Interferon alfa-2a, Recombinant and Niraparib 

Recommended Action
      Management Caution is advised if niraparib is prescribed with other myelosuppressive agents.

References
1 Product Information. Zejula (niraparib). Tesaro Inc., Waltham, MA.